摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(7H-嘌呤-6-基)辛酰胺 | 52854-12-3

中文名称
N-(7H-嘌呤-6-基)辛酰胺
中文别名
——
英文名称
N6-octanoyladenine
英文别名
N-(7H-purin-6-yl)octanamide
N-(7H-嘌呤-6-基)辛酰胺化学式
CAS
52854-12-3
化学式
C13H19N5O
mdl
——
分子量
261.327
InChiKey
BCHNDUIHZPOJOY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    83.6
  • 氢给体数:
    2
  • 氢受体数:
    4

SDS

SDS:702aaa26ac42587979b56efd3c88c208
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(7H-嘌呤-6-基)辛酰胺N,O-双三甲硅基乙酰胺三氟甲磺酸三甲基硅酯 作用下, 以 乙腈 为溶剂, 反应 2.25h, 生成 α-3'-azido-2',3'-dideoxyadenosine
    参考文献:
    名称:
    大肠杆菌的核苷转运蛋白NupC和NupG:配体结合所必需的特定结构基序。
    摘要:
    测试了一系列46种天然核苷和类似物(主要是基于腺苷的)作为从大肠杆菌中富集的,与H(+)连接的核苷转运蛋白NupC和NupG吸收[U-(14)C]尿苷的抑制剂。这两个在进化上不相关的转运蛋白显示出相似但不同的抑制模式,揭示了对不同核苷及其类似物的不同选择性。核苷与NupG的结合需要在核糖的C-3'和C-5'位置分别存在羟基,而与NupC的结合仅需要C-3'羟基取代基。核糖部分对于结合NupG的重要性更高,与该蛋白质和寡糖之间的进化关系一致:运输者的主要促进者超家族(MFS)的H(+)同向转运蛋白(OHS)亚家族。对于两种蛋白质,C-3'处的天然α-构型和C-1'处的天然β-构型对于配体结合都是必需的。发现腺苷的咪唑环中的N-7和C-6的氨基对于结合并不重要,并且两个转运蛋白都显示出C-6 / N取代的灵活性。N-1和N-3中的一个或两个对腺苷类似物与NupC的结合很重要,但对NupG的结合
    DOI:
    10.1039/b414739a
  • 作为产物:
    参考文献:
    名称:
    Isolation and synthesis of N-acyladenine and adenosine alkaloids from a southern Australian marine sponge, Phoriospongia sp.
    摘要:
    Chemical fractionation of the southern Australian marine sponge Phoriospongia sp. (CMB-03107) yielded phorioadenine A (1) as a nematocidal agent and the first reported example of a 6-N-acyladenine natural product. The structure of 1 was confirmed by spectroscopic analysis and the chemical synthesis of racemic (1a) and enantiomeric (1b) analogues. HPLC-ESIMS analysis of the crude sponge extract with comparisons to the synthetic 6-N-acyladenosine 2a provided evidence that the biosynthetically related adenosine, phorioadenosine A (2), was present as a trace co-metabolite. The rare starfish metabolite asterubine (3) was also isolated as a co-metabolite, and its structure confirmed by spectroscopic analysis and chemical synthesis. Biological investigations confirmed that natural products 1-3 and synthetic analogues la-e and 2a were not cytotoxic to multiple mammalian cancer cell lines, or Gram-positive or -negative bacteria. Nematocidal activity (inhibition of larval development of Haemonchus contortus) detected in the Phoriospongia sp. extract was attributed to 1 (LD99 31 mu g/mL), with preliminary structure-activity relationship investigations confirming the importance of the N-acyl side chain. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2014.08.116
点击查看最新优质反应信息

文献信息

  • Efficient and improved synthesis of triazole-linked DNA (TLDNA) oligomers
    作者:Tomoko Fujino、Naomi Yamazaki、Ai Hasome、Kenta Endo、Hiroyuki Isobe
    DOI:10.1016/j.tetlet.2011.12.026
    日期:2012.2
    A method for the synthesis of triazole-linked DNA oligomers has been revisited to incorporate a reliable protective group and linker for solid-phase synthesis. The new solid-phase synthesis allowed the preparation of oligomers with the efficiency of elongation reaching over 90%.
    已经重新考虑了合成三唑连接的DNA低聚物的方法,以结合可靠的保护基和用于固相合成的接头。新的固相合成方法可以制备低聚物,其延伸效率达到90%以上。
  • Efficient synthesis of 2′-C-α-aminomethyl-2′-deoxynucleosides
    作者:Nan-Sheng Li、Joseph A. Piccirilli
    DOI:10.1039/c2cc34556k
    日期:——
    Starting from methyl 3,5-di-O-benzyl-2-keto-alpha-D-ribofuranoside, a convergent, six-step synthesis is developed to give efficiently all four 2'-C-alpha-aminomethyl-2'-deoxynucleosides (U, C, A, G) in 38%, 42%, 12%, 12% yield, respectively. Convergence is achieved by the glycosylation of persilylated nucleobases with methyl 2-alpha-phthalimidomethyl ribofuranoside.
    从甲基3,5-二-O-苄基-2-酮基的α-d呋喃核糖苷,会聚开始,六步合成进行显影,得到有效地所有四个2'-C-α-氨基甲基-2'-脱氧核苷(U,C,A,G)在38%,42%,分别为12%,产率12%。收敛通过全硅烷化的核碱基的糖基化与甲基2-α-苯二甲酰呋喃核糖苷实现。
  • Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
    申请人:——
    公开号:US20030013880A1
    公开(公告)日:2003-01-16
    A process for the preparation of 1,3-oxathiolane nucleoside analogues in predominantly the cis-form, from mixture of cis-/trans-1,3-oxathiolane nucleosides or their protected derivatives thereof, comprising: (i) treatment of the cis-/trans-1,3-oxathiolane nucleosides (or protected derivatives thereof) with a pyrimidine base (or it derivatives thereof) and an acid, (ii) adding a suitable acid to the obtained cis-/trans-mixture of isomers, (iii) selective crystallization of the desired cis-isomer salt from a solvent or combination of solvents, and (iv) treatment of the predominantly cis-isomer salt with a suitable base to offer the free 1,3-oxathiolane nucleosides, and thereafter optionally repeating steps (i) to (iv) inclusive.
    一种制备1,3-氧硫环己烷核苷类似物的方法,其主要为顺式形式,从顺/反-1,3-氧硫环己烷核苷或其受保护衍生物混合物中制备,包括:(i)将顺/反-1,3-氧硫环己烷核苷(或其受保护衍生物)与嘧啶碱基(或其衍生物)和酸处理,(ii)向得到的顺/反异构体混合物中加入适当的酸,(iii)从溶剂或溶剂组合中选择性结晶所需的顺异构体盐,(iv)用适当的碱处理主要为顺异构体盐以提供自由的1,3-氧硫环己烷核苷,然后可选地重复步骤(i)至(iv)。
  • Therapeutic nucleosides
    申请人:THE WELLCOME FOUNDATION LIMITED
    公开号:EP0217580A2
    公开(公告)日:1987-04-08
    The present invention relates to certain novel 3'- azidonucleosides and pharmaceutically acceptable derivatives thereof; the use of certain 3'-azidonucleosides, their pharmaceutically acceptable derivatives and therapeutic combinations containing them, in therapy, particularly in the treatment and prophylaxis of gram negative bacterial infections and retroviral infections, especially AIDS; to processes for the preparation of 3'-azidonucleosides; and to formulations containing them.
    本发明涉及某些新型 3'-叠氮核苷及其药学上可接受的衍生物;某些 3'-叠氮核苷、其药学上可接受的衍生物和含有它们的治疗组合物在治疗中的用途,特别是在革兰氏阴性细菌感染和逆转录病毒感染(尤其是艾滋病)的治疗和预防中的用途;3'-叠氮核苷的制备工艺;以及含有它们的制剂。
  • Artificial Nucleosides Possessing Metal Binding Sites at the 3‘- and 5‘-Positions of the Deoxyribose Moieties
    作者:Jun-ya Chiba、Kentaro Tanaka、Yukinori Ohshiro、Ryosuke Miyake、Shuichi Hiraoka、Motoo Shiro、Mitsuhiko Shionoya
    DOI:10.1021/jo026026l
    日期:2003.1.1
    This paper describes a convenient synthetic procedure for nucleoside mimics, 1-6, in which the 3',5'-hydroxy groups of natural 2'-deoxythymidine or 2'-deoxyadenosine are replaced by thiol, amine, or alkylthiol groups. Such nucleosides would be built up into a single DNA strand with cooperative participation of metal coordination, where internucleoside linkages are replaced by metal complexation motifs. The X-ray crystal structure and complexation behaviors of 3',5'-dithiothymidine, 1, with Au-I are also reported.
查看更多